Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3223]

FDA approves updated drug labeling for fludarabine phosphate under Project Renewal

FDA approves updated drug labeling for fludarabine phosphate under Project Renewal

$FDA approves revumenib for relapsed or refractory acute leukaemia with a KMT2A translocation$

FDA approves revumenib for relapsed or refractory acute leukaemia with a KMT2A translocation

Innovative test may improve mesothelioma detection rate in blood

Innovative test may improve mesothelioma detection rate in blood

A common heart failure medication may help prevent heart damage related to chemotherapy

A common heart failure medication may help prevent heart damage related to chemotherapy

Glioblastoma: new treatment attacks brain tumors from multiple angles

Glioblastoma: new treatment attacks brain tumors from multiple angles

$FDA approves obecabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia$

FDA approves obecabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic...

Groundbreaking research unlocks precision therapy for drug-resistant leukaemia

Groundbreaking research unlocks precision therapy for drug-resistant leukaemia

Study reveals how cancer immunotherapy leads to deadly form of heart inflammation in some patients

Study reveals how cancer immunotherapy leads to deadly form of heart inflammation in some patients

'Black box' of stem cell transplants opened in world-first blood study

'Black box' of stem cell transplants opened in world-first blood study

In landmark study, immunotherapy boosts survival of advanced Hodgkin lymphoma

In landmark study, immunotherapy boosts survival of advanced Hodgkin lymphoma

More from ecancer